Here are four takeaways:
1. SonicOne O.R. uses ultrasonic technology for wound debridement.
2. One study found SonicOne O.R. had a 90 percent success rate in the take of a skin graft when used to prepare the wound bed graft site.
3. Another study showed SonicOne O.R. decreased the bacterial load so a patient’s wound could heal.
4. Two other abstracts were also presented at the 2016 Diabetic limb Salvage Conference in Washington, D.C.
“As the clinical evidence continues to build, the opportunity exists to establish SonicOne O.R. as the gold standard for wound debridement,” said Scott Ludecker, senior vice president of global sales and marketing, Misonix.
More articles on devices:
Medovex to attend BritSpine 2016 conference: 6 notes
7 points on Implanet’s 2015 annual report
FDA clears Renovis’ 3-D printed cervical cage: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
